A-Share Market Overview - The A-share market experienced an overall decline in the first week of August, with small-cap growth sectors showing smaller declines compared to large-cap growth sectors. The CSI 2000 index fell by 0.01%, while the ChiNext index decreased by 0.74%. In contrast, the Northbound 50 index dropped by 2.70% [5] - The decline in the market was largely driven by significant drops in upstream resource products, with non-ferrous metals down by 4.69%, coal down by 4.56%, and building materials down by 3.32%. The political bureau meeting at the end of July adjusted its stance on "anti-involution," leading to a relative cooling of the policy's intensity, which contributed to the pullback in the upstream resource sector [5] - Looking ahead, the political bureau meeting's outcomes were in line with expectations, maintaining a steady overall policy stance. The report anticipates that the A-share market will continue to experience structural upward fluctuations driven by valuation recovery under a dual easing environment of fiscal and monetary policy [5] Hong Kong Market Overview - The Hong Kong market also saw a significant pullback in the first week of August, with the Hang Seng Index declining by 3.47% and the Hang Seng Tech Index falling by 4.94%. The materials and information technology sectors experienced the largest declines, while healthcare and telecommunications sectors rose against the trend [6] - The pullback in the Hong Kong market was influenced by the fading sentiment around "anti-involution," which affected previously high-performing upstream resource stocks. Additionally, weakened sales expectations in the home appliance sector led to significant declines in consumer discretionary stocks like Midea. The internet and social services sector in Hong Kong also faced declines due to weakened consumption expectations [6] - The report suggests that while market sentiment has cooled, the internet and social services sector in Hong Kong is currently at a low valuation, indicating potential for upward movement. Furthermore, with rising AI capital expenditures and increased support for technological innovation policies, leading companies in the Hang Seng Tech sector are expected to have medium to long-term growth potential [6]

Quantitative Models and Construction Methods 1. Model Name: Hong Kong Stock Selection Portfolio Strategy - **Model Construction Idea**: The strategy is based on a dual-layer selection process that integrates fundamental and technical analysis. It aims to identify stocks with both fundamental support and technical resonance from an analyst-recommended stock pool[13][14] - **Model Construction Process**: 1. **Analyst Recommendation Pool**: Constructed using three types of analyst recommendation events: upward earnings forecast revisions, initial analyst coverage, and research reports with unexpected positive titles[14] 2. **Dual-Layer Screening**: - **Fundamental Screening**: Select stocks with strong fundamental support - **Technical Screening**: Identify stocks with technical resonance 3. **Portfolio Backtesting**: The backtesting period spans from January 1, 2010, to June 30, 2025. The portfolio assumes a fully invested position and accounts for transaction costs[14] - **Model Evaluation**: The strategy demonstrates strong performance, with an annualized return of 19.11% and an excess return of 18.48% relative to the Hang Seng Index over the backtesting period[14] 2. Model Name: Stable New High Stock Screening - **Model Construction Idea**: This model leverages the momentum effect, which is particularly significant in the Hong Kong stock market. It identifies stocks that have recently reached a 250-day high and exhibit stable price paths[19][21] - **Model Construction Process**: 1. **250-Day High Distance Calculation**: $ 250\text{-Day High Distance} = 1 - \frac{\text{Close}_{\text{latest}}}{\text{ts\_max}(\text{Close}, 250)} $ - $\text{Close}_{\text{latest}}$: Latest closing price - $\text{ts\_max}(\text{Close}, 250)$: Maximum closing price over the past 250 trading days[21] 2. **Screening Criteria**: - **Analyst Attention**: At least five "Buy" or "Overweight" ratings in the past six months - **Relative Strength**: Top 20% in 250-day price change within the sample pool - **Price Stability**: Top 50% based on a composite score of price path smoothness and new high persistence[22] - **Trend Continuation**: Top 50 stocks based on the average 250-day high distance over the past five days[22] - **Model Evaluation**: The model effectively identifies stocks with strong momentum and stable price paths, making it a useful tool for trend-following strategies[19][21] --- Model Backtesting Results 1. Hong Kong Stock Selection Portfolio Strategy - **Annualized Return**: 19.11% - **Excess Return (Relative to Hang Seng Index)**: 18.48% - **Maximum Drawdown**: 23.73% - **Information Ratio (IR)**: 1.22 - **Tracking Error**: 14.55% - **Return-to-Drawdown Ratio**: 0.78[18] 2. Stable New High Stock Screening - **Sector Distribution**: - **Healthcare**: 16 stocks - **Finance**: 9 stocks - **Technology**: 8 stocks - **Consumer**: 8 stocks - **Cyclicals**: 3 stocks[21][22]

Market Performance - Developed markets outperformed last week, with MSCI global index up by 1.3%, MSCI developed markets up by 1.4%, and MSCI emerging markets up by 0.7% [3] - Among developed markets, Nikkei 225 had the strongest performance (+4.1%), while S&P/ASX 200 was the weakest (-1.0%) [3] - In emerging markets, ChiNext Index was the best performer (+2.8%), while India’s Sensex 30 was the worst (-0.4%) [3] Trading Sentiment - Trading volume increased in Hong Kong and European markets, while it decreased in the US market [10][11] - Hong Kong's Hang Seng Index saw a trading volume of 186 billion shares and a turnover of 705.5 billion USD, reflecting a week-on-week increase [11] - The short-selling ratio in Hong Kong decreased to 11.5%, indicating high investor sentiment [11] Valuation - Developed markets' overall valuation improved, with the latest PE and PB ratios at 23.8x and 3.8x, respectively, placing them in the 93% and 100% percentile levels since 2010 [13] - Nasdaq and Dow Jones Industrial Average had the highest PE ratios at 43.1x and 32.0x, respectively [13] - Emerging markets also saw a valuation increase, with PE and PB ratios at 16.5x and 2.0x, respectively, in the 86% and 92% percentile levels since 2010 [14] Fund Flows - Global macro liquidity expectations tightened, with significant capital inflows into France, Germany, and India, while outflows were noted from the US [19][21] - In Hong Kong, a total of 21.3 billion HKD flowed into the market, with stable foreign capital inflows of 13.4 billion HKD [21] Earnings Expectations - Hong Kong's consumer sector saw an upward revision in earnings expectations, with the Hang Seng Index's 2025 EPS forecast adjusted from 2215 to 2210 [22] - The US S&P 500's earnings expectations remained stable at 265, while the Eurozone's STOXX50 index saw a slight downward adjustment from 338 to 337 [22][23]

Group 1: Market Outlook - The report maintains an optimistic outlook for the Hong Kong stock market in the second half of 2025, predicting a potential upward trend for the Hang Seng Index, which is expected to reach 27,500 points by the end of December 2025, based on a forecasted P/E ratio of 12.2 times [2][30] - The Chinese decision-makers are expected to implement incremental policies to strengthen domestic circulation, promote supply-side reforms, and expand domestic consumption demand [2][30] - The report highlights attractive valuation levels in the current Hong Kong stock market, suggesting that the market is currently in a historically lower valuation range compared to previous years [2][31] Group 2: Sector Performance - In the first half of 2025, the Hong Kong stock market outperformed other major global markets, with the Hang Seng Index rising by 20.0% and the Hang Seng Tech Index by 18.68% [3][4] - The healthcare, materials, and information technology sectors showed strong performance, with respective increases of 47.7%, 45.6%, and 29.8% [4][7] - The report notes that the premium of A-shares over H-shares has decreased, indicating a narrowing gap in valuations between the two markets [4][16] Group 3: Investment Opportunities - Key investment opportunities are identified in areas such as supply-side reform, infrastructure development, and consumer-driven companies, particularly those with low valuations and high dividend yields [2][30] - The report emphasizes the importance of focusing on leading consumer companies and domestic brands that are benefiting from accelerated domestic substitution processes [2][30] - The ongoing infrastructure projects, such as the construction of the largest hydropower station in China, are expected to benefit related sectors, including construction, machinery, and materials [2][38] Group 4: Capital Market Dynamics - The Hong Kong capital market remains liquid, with significant inflows from southbound trading, which accounted for 22.1% of total market turnover by June 30, 2025 [17][23] - The report indicates that the IPO financing amount in Hong Kong reached $141 billion in the first half of 2025, marking a 695% year-on-year increase, positioning Hong Kong as the top global IPO market [17][23] - The report also highlights the impact of geopolitical risks on market sentiment, noting that companies with mainland backgrounds dominate the Hong Kong market, comprising 80.97% of total market capitalization [24]

Core Viewpoint - The Hong Kong stock market saw a collective surge in the pharmaceutical and biotechnology sector, with notable gains in companies like Li Auto and China Biologic Products [2][4][12]. Group 1: Market Performance - The Hang Seng Index closed at 24,498.95 points, down 0.08%, while the Hang Seng Tech Index rose by 0.56% to 5,448.85 points [2]. - The total market turnover was HKD 236.4 billion, a decrease from the previous trading day, with net inflows from southbound funds amounting to HKD 1.855 billion [2]. - Among the constituent stocks, 43 rose and 40 fell, with Li Auto leading the gains at 9.73% [4]. Group 2: Notable Stock Movements - Li Auto's stock price increased by 9.73%, closing at HKD 124.10, with a year-to-date increase of 32.09% [5][19]. - China Biologic Products rose by 5.90%, with a significant year-to-date increase of 114.68% [5]. - The pharmaceutical sector saw a strong performance, with the Wande Pharmaceutical and Biotechnology Index rising by 4.65% [15]. Group 3: Sector Analysis - The healthcare sector increased by 5.17%, while the materials and energy sectors experienced declines of 1% and 0.94%, respectively [6]. - The CAR-T index rose by 8.19%, and the unprofitable biotech index increased by 6.28%, indicating strong investor interest in these areas [9]. Group 4: Regulatory Developments - The National Healthcare Security Administration and the National Health Commission introduced measures to support the high-quality development of innovative drugs, which is expected to enhance the role of commercial insurance in the multi-level medical security system [17]. - This regulatory change is anticipated to positively impact the upstream supply chain, including research reagents and CXO industries, with expected performance improvements starting from mid-2025 [17]. Group 5: Company-Specific News - Li Auto announced the opening of pre-orders for its i8 model, leading to a stock price increase of nearly 10% [18][19]. - The expected price range for the i8 is between RMB 350,000 and RMB 400,000, with the official price to be announced on July 29 [22].

Group 1 - A-shares have shown a structural market characteristic, with strong performance in consumer sectors such as food and beverage, and retail, as well as certain technology sectors like AI applications and innovative pharmaceuticals [2][4] - The top five performing industries in A-shares include agriculture, media, food and beverage, electrical equipment, and retail, indicating a growing interest in agricultural assets and a recovery in consumer spending [2] - The bottom five performing industries in A-shares are electronics, steel, basic chemicals, non-ferrous metals, and storage chips, with the decline in non-ferrous metals linked to proposed US tariffs on copper [2] Group 2 - In the Hong Kong market, the healthcare sector has seen a rise due to active innovative drug concepts, despite potential US tariffs on pharmaceuticals [3] - The top three performing industries in Hong Kong include healthcare, industrial, and energy, while the bottom three are materials, information technology, and real estate, reflecting external pressures from US tariff policies and global tech supply-demand imbalances [3] - The current market characteristics indicate that A-shares are driven by policy and sectoral improvements, while Hong Kong stocks are more influenced by external factors such as US tariffs and global technology cycles [4] Group 3 - Short-term market hotspots are concentrated around policy-driven sectors and improving industry conditions, with a focus on performance in the upcoming earnings reports [4] - The breakthrough of the Shanghai Composite Index above 3500 points is expected to further boost market confidence, with potential policy signals from the July Politburo meeting influencing capital flows [4]

Market Performance - The Hong Kong stock market has outperformed major global markets since 2025, with the Hang Seng Index and Hang Seng Tech Index both showing over 21% cumulative gains as of June 11, 2023 [1] - The net inflow of southbound funds has exceeded 670 billion HKD this year, setting a historical record for the same period, significantly boosting the market's performance [1] - Nearly 80% of the stocks in the Hang Seng Index have risen, with BYD leading the charge with over 60% growth [1] Sector Performance - The healthcare, materials, and information technology sectors have led the market, with gains of 50.54%, 36.41%, and 28.32% respectively [1] - The financial and discretionary consumer sectors have also recorded gains exceeding 22% [1] Investment Outlook - Analysts from CICC highlight structural advantages in the Chinese macro and market environment, such as stable dividend returns and growth lines in new consumption, AI technology, and innovative pharmaceuticals, making Hong Kong stocks more attractive compared to other markets [3] - Multiple brokerage firms maintain an optimistic outlook for the second half of the year, with expectations of a rebound in valuations and earnings in the fourth quarter [3] - Predictions suggest that southbound capital inflows could reach between 200 billion to 300 billion HKD in the second half, with total annual inflows potentially exceeding 1 trillion HKD [3] Investment Recommendations - CICC recommends focusing on stable returns (like deposits, government bonds, and dividend assets) and growth returns (such as technology, new consumption, and innovative pharmaceuticals) [4] - Huatai Securities identifies consumption and technology as key investment themes, favoring internet consumption, pharmaceuticals, personal care products, and hard tech sectors [4] - The primary market for Hong Kong stocks is showing signs of recovery, with opportunities in the brokerage sector due to increased demand for cross-border wealth management [4]

港股市场策略周报 2025.6.2-2025.6.8 | 分析师： | 沈凡超 | | --- | --- | | 中央编号： | BTT231 | | 联系电话： | 852-4623 5564 | | 邮箱： | hector@cnzsqh.hk | 港股市场策略周报 - 投资要点 l 港股市场表现回顾： l 港股市场宏观环境： l 港股市场展望： 2 n 本周中美关税摩擦继续缓和，结合政策加力的预期，港股市场本周迎来反弹，恒生综指/恒生指数/恒生科技分别 +2.20%/+2.16%/+2.25%。本周市场一级行业板块多数收涨，原材料业涨幅排在第一，周涨幅超5.5%；医疗 保健业继续保持强势，周涨幅超4.0%，排在第二。 n 截至本周末，恒生综指的5年PE（TTM）估值分位点升至72.3%，估值水平略超5年均值。 n 基本面：央行本周打破惯例，在6月初首次开展1万亿元买断式逆回购操作，释放明确宽松信号。 n 资金面：5月美国非农虽较上月走弱，但超市场预期，就业市场仍有韧性，市场对于美联储降息的预期继续承压。 n 基本面：经济复苏的内生动能仍然偏弱，外需承压下内需仍待政策面托举；政策面： 货币政策持续宽松加 ...

港股交易热度持续高涨, 业绩关注度逐渐提升 2025 年 02 月 23 日 核心观点: 分析师 杨超 ☎：010-8092-7696 网: yangchao_yj@chinastock.com.cn 分析师登记编码：S0130522030004 策略研究 · 周度报告 www.chinastock.com.cn 证券研究报告 请务必阅读正文最后的中国银河证券股份有限公司免责声明 ● 本周港股市场回顾：（1）行情表现：本周（2月 17 日-2 月 21 日），全球股 指涨跌互现。其中,港股再次领涨全球权益指数;台股、A 股、韩国股市、越 南股市总体上涨;美股、泰国股市、德国股市、日本股市、英国股市、印度股 市、法国股市等小幅下跌。(2)本周港股市场延续强势上行格局,恒生指数、 恒生科技指数、国企指数分别累计上涨 3.79%、6.03%、4.02%。行业层面, 7 个恒生综合行业指数上涨,5个行业下跌。其中,资讯科技业、医疗保健业、 电讯业涨幅居前,分别上涨 10.34%、8.81%、6.01%;原材料业、能源业、地 产建筑业跌幅居前,分别下跌 3.07%、2.45%、0.53%。（3）情绪面：本周港 交所日均 ...